Failure to recapture cardioprotection with high-dose atorvastatin in coronary artery bypass surgery: A randomised controlled trial

Basic Research in Cardiology

Volumn 106, Issue 6, 2011, Pages 1387-1395

  Ludman, Andrew J ^a   Hausenloy, Derek J ^a   Babu, Girish ^a   Hasleton, Jonathon ^a   Venugopal, Vinod ^a   Boston Griffiths, Edney ^a   Yap, John ^a   Lawrence, David ^a   Hayward, Martin ^a   Kolvekar, Shyam ^a   Bognolo, Giulio ^a   Rees, Paul ^a   Yellon, Derek M ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Atorvastatin; Cardioprotection; Coronary artery bypass graft surgery

Indexed keywords

ATORVASTATIN; CREATINE KINASE; TROPONIN T;

ABSENCE OF SIDE EFFECTS; ACUTE DRUG ADMINISTRATION; ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DOSE RESPONSE; DRUG MEGADOSE; DRUG SAFETY; ELECTIVE SURGERY; ENZYME RELEASE; FEMALE; HEART MUSCLE INJURY; HEART PROTECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; PREOPERATIVE PERIOD; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SURGICAL TECHNIQUE;

AREA UNDER CURVE; CORONARY ARTERY BYPASS; CREATINE KINASE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; POSTOPERATIVE COMPLICATIONS; PYRROLES; SINGLE-BLIND METHOD; TROPONIN T;

EID: 84856744093     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-011-0209-5     Document Type: Article

References (37)

1. Bell RM, Yellon DM (2003) Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway. J Am Coll Cardiol 41:508-515. doi:10.1016/S0735-1097(02) 02816-4 (Pubitemid 36164511)
2. Birnbaum Y, Lin Y, Ye Y, Martinez JD, Huang MH, Perez-Polo JR, Uretsky BF (2007) Aspirin before reperfusion blunts the infarct size limiting effect of atorvastatin. J Am Coll Cardiol 49:184A. doi:10.1016/j.jacc.2007.01.039
3. Birnbaum Y, Ye Y, Lin Y, Freeberg SY, Nishi SP, Martinez JD, Huang MH, Uretsky BF, Perez-Polo JR (2006) Augmentation of myocardial production of 15-epi-lipoxin-A (4) by pioglitazone and atorvastatin in the rat. Circulation 114:929-935. doi: 10.1161/circulationAHA.106.629907 (Pubitemid 44337136)
4. Collard CD, Body SC, Shirnan SK, Wang S, Mangano DT (2006) Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 132:392-400. doi:10.1016/j.jtcvs.2006.04.009 (Pubitemid 44092868)
5. Di Sciascio G, Patti G, Pasceri V, Gaspardone A, Colonna G, Montinaro A (2009) Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for reduction of myocardial damage during angioplasty) randomized trial. J Am Coll Cardiol 54:558-565. doi:10.1016/j. jacc.2009.05.028
6. Domanski MJ, Mahaffey K, Hasselblad V, Brener SJ, Smith PK, Hillis G, Engoren M, Alexander JH, Levy JH, Chaitman BR, Broderick S, Mack MJ, Pieper KS, Farkouh ME (2011) Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery. JAMA 305:585-591. doi: 10.1001/jama.2011.99
7. Endres M, Laufs U, Huang Z, Nakamura T, Huang P, Moskowitz MA, Liao JK (1998) Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci USA 95:8880-8885 (Pubitemid 28350583)
8. Engelhorn T, Doerfler A, Heusch G, Schulz R (2006) Reduction of cerebral infarct size by the AT1-receptor blocker candesartan, the HMG-CoA reductase inhibitor rosuvastatin and their combination. An experimental study in rats. Neurosci Lett 406:92-96. doi:10.1016/j.neulet.2006.07.022 (Pubitemid 44278379)
9. Ferdinandy P, Schulz R, Baxter GF (2007) Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev 59:418-458. doi:10.1124/pr.107.06002
10. Hausenloy DJ, Mwamure P, Venugopal V, Harris J, Barnard M, Grundy E, Ashley E, Vichare S, Di Salvo C, Kolvekar S, Hayward M, Keogh B, MacAllister RJ, Yellon DM (2007) Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet 370:575-579. doi: 10.1016/S0140-6736(07) 61296-3 (Pubitemid 47247853)
11. Hausenloy DJ, Baxter G, Bell R, Botker HE, Davidson SM, Downey J, Heusch G, Kitakaze M, Lecour S, Mentzer R, Mocanu MM, Ovize M, Schulz R, Shannon R, Walker M, Walkinshaw G, Yellon DM (2010) Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations. Basic Res Cardiol 105:677-686. doi:10.1007/s00395-010-0121-4
12. Hausenloy DJ, Yellon DM (2004) New directions for protecting the heart against ischaemia-reperfusion injury: targeting the reperfusion injury salvage kinase (RISK)-pathway. Cardiovasc Res 61:448-460. doi:10.1016/j.cardiores.2003. 09.024 (Pubitemid 38210151)
13. Hausenloy DJ, Yellon DM (2007) Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. Heart Fail Rev 12:217-234. doi:10.1007/s10741-007-9026-1 (Pubitemid 350176695)
14. Herrmann J, Lerman A, Baumgart D, Volbracht L, Schulz R, von Birgelen C, Haude M, Heusch G, Erbel R (2002) Preprocedural statin medication reduces the extent of periprocedural non-Q-wave myocardial infarction. Circulation 106:2180-2183. doi: 10.1161/01. CIR.0000037520.89770.5E (Pubitemid 35222209)
15. Heusch G, Kleinbongard P, Bose D, Levkau B, Haude M, Schulz R, Erbel R (2009) Coronary microembolization: from bedside to bench and back to bedside. Circulation 120:1822-1836. doi: 10.1161/CIRCULATIONAHA.109.888784
16. Iliodromitis EK, Andreadou I, Prokovas E, Zoga A, Farmakis D, Fotopoulou T, Ioannidis K, Paraskevaidis IA, Kremastinos DT (2010) Simvastatin in contrast to postconditioning reduces infarct size in hyperlipidemic rabbits: possible role of oxidative/nitrosative stress attenuation. Basic Res Cardiol 105:193-203. doi: 10.1007/s00395-009-0078-3
17. Kulik A, Brookhart MA, Levin R, Ruel M, Solomon DH, Choudhry NK (2008) Impact of statin use on outcomes after coronary artery bypass graft surgery. Circulation 118:1785-1792. doi: 10.1161/CIRCULATIONAHA.108.799445
18. Lehrke S, Steen H, Sievers HH, Peters H, Opitz A, Muller-Bardorff M, Wiegand UK, Katus HA, Giannitsis E (2004) Cardiac troponin T for prediction of short-and long-term morbidity and mortality after elective open heart surgery. Clin Chem 50:1560-1567. doi:10.1373/clinchem.2004.031468 (Pubitemid 39121224)
19. Liakopoulos OJ, Choi YH, Haldenwang PL, Strauch J, Wittwer T, Dorge H, Stamm C, Wassmer G, Wahlers T (2008) Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30, 000 patients. Eur Heart J 29:1548-1549. doi:10.1093/eur heartj/ehn198
20. Ludman AJ, Yellon DM, Hausenloy DJ (2010) Cardiac preconditioning for ischaemia: lost in translation. Dis Model Mech 3:35-38. doi:10.1242/dmm.003855
21. Ludman A, Venugopal V, Yellon DM, Hausenloy DJ (2009) Statins and cardioprotection-more than just lipid lowering? Pharmacol Ther 122:30-43. doi:10.1016/j.pharmthera.2009.01. 002
22. Mannacio VA, Iorio D, De AV, Di Lello F, Musumeci F (2008) Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. J Thorac Cardiovasc Surg 136:1541-1548. doi:10.1016/j.jtcvs. 2008.06.038
23. Mensah K, Mocanu MM, Yellon DM (2005) Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment: a potential role for phosphatase and tensin homolog deleted on chromosome ten? J Am Coll Cardiol 45:1287-1291. doi: 10.1016/j.jacc.2005.01.021 (Pubitemid 40523151)
24. Pasceri V, Patti G, Nusca A, Pristopino C, Richichi G, Di Sciascio G (2004) Randomised trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (atorvastatin for reduction of myocardial damage during angioplasty) study. Circulation 110:674-678. doi: 10.1161/01. CIR.0000137828.06205.87 (Pubitemid 39056265)
25. Patti G, Pasceri V, Colonna G, Miglionico M, Fischetti D, Sardella G, Montinaro A, Di Sciascio G (2007) Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention. Results of the ARMYDA-ACS randomised trial. J Am Coll Cardiol 49:1272-1278. doi:10.1016/j.jacc.2007.02.025 (Pubitemid 46467240)
26. Raal FJ, Pappu AS, Illingworth DR, Pilcher GJ, Marais AD, Firth JC, Kotze MJ, Heinonen TM, Black DM (2000) Inhibition of cholesterol synthesis by atorvastatin in homozygous familial hypercholesterolaemia. Atherosclerosis 150:421-428. doi: 10.1016/S0021-9150(99) 00435-9 (Pubitemid 30336555)
27. Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters D, Zeiher A, Chaitman BR, Leslie S, Stern T (2001) Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 285:1711-1718. doi:10.1001/jama.285.13. 1711 (Pubitemid 32259905)
28. Skyschally A, van Caster P, Boengler K, Gres P, Musiolik J, Schilawa D, Schulz R, Heusch G (2009) Ischemic postconditioning in pigs: no causal role for RISK activation. Circ Res 104:15-18. doi:10.1161/CIRCRESAHA.108.186429
29. Sun YM, Tian Y, Li X, Liu YY, Wang LF, Li J, Li ZQ, Pan W (2009) Effect of atorvastatin on expression of IL-10 and TNF-alpha mRNA in myocardial ischemia-reperfusion injury in rats. Biochem Biophys Res Commun 382:336-340. doi:10.1016/j. bbrc.2009.03.019
30. Szarszoi O, Maly J, Ostadal P, Netuka I, Besik J, Kolar F, Ostadal B (2008) Effect of acute and chronic simvastatin treatment on post-ischemic contractile dysfunction in isolated rat heart. Physiol Res 57:793-796
31. Takemoto M, Liao JK (2001) Pleiotropic effects of 3-hydroxy-3- methylglutaryl coenzyme a reductase inhibitors. Arterioscler Thromb Vasc Biol 21:1712-1719. doi:10.1161/hq1101.098486 (Pubitemid 34219772)
32. (2008) The Society of Cardiothoracic Surgeons of Great Britain and Ireland. The 6th National Adult Cardiac Surgical Database Report. Dendrite Clinical Systems Ltd
33. Thielmann M, Kottenberg E, Boengler K, Raffelsieper C, Neuhaeuser M, Peters J, Jakob H, Heusch G (2010) Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest. Basic Res Cardiol 105:657-664. doi:10.1007/s00395-010-0104- 5
34. Thygesen K, Alpert JS, White HD (2007) Universal definition of myocardial infarction. Circulation 116:2634-2653. doi: 10.1161/CIRCULATIONAHA.107.187397 (Pubitemid 350182388)
35. Venugopal V, Hausenloy DJ, Ludman A, Di Salvo C, Kolvekar S, Yap J, Lawrence D, Bognolo G, Yellon DM (2009) Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold blood cardioplegia: a randomised controlled trial. Heart 95:1567-1571. doi:10.1136/hrt. 2008.155770
36. Venugopal V, Ludman A, Yellon DM, Hausenloy DJ (2009) Conditioning' the heart during surgery. Eur J Cardiothorac Surg 35:977-987. doi:10.1016/j.ejcts. 2009.02.014
37. Yao L, Chen GP, Lu X, Zheng LR, Mou Y, Hu SJ (2009) Effects of atorvastatin on calcium-regulating proteins: a possible mechanism to repair cardiac dysfunction in spontaneously hypertensive rats. Basic Res Cardiol 104:258-268. doi:10.1007/s00395-008-0751-y